CIMIVIR LTM
Biocon shares gain over 5%, hit 52-week high intra-dayShares of biotechnology major Biocon today surged over 5 per cent after the company launched advanced novel therapy for the treatment of He...
Biocon introduces advanced therapy to treat Hepatitis CBiotechnology major Biocon launches advanced novel therapy for the treatment of Hepatitis C at a fraction of the global cost.
- Load More